CDC: Those who got Pfizer vaccine should now seek booster after 5 months; Previous guidance said to wait 6 months
On Tuesday, the Centers for Disease Control and Prevention updated recommendations for booster shots, saying that people who got the Pfizer vaccine should now seek out a booster shot five months after their second shot.
Those who received the single-dose Johnson & Johnson vaccine should still seek a booster shot two months after their initial dose. Those who got the two-dose Moderna mRNA vaccine should still seek a booster six months after their final dose. "As we have done throughout the pandemic, we will continue to update our recommendations to ensure the best possible protection for the American people," CDC Director Dr. Rochelle Walensky said in a statement.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA expands Pfizer boosters for more teens as omicron surges | AP NewsThe U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12. Boosters already are recommended for everyone 16 and older, and federal regulators on Monday decided they’re also warranted for 12- to 15-year-olds once enough time has passed since their last dose.
Lire la suite »
Pediatrician answers your questions on Pfizer Covid-19 booster for ages 12-15The FDA gave emergency use authorization for booster doses of Pfizer/BioNTech's Covid-19 vaccine for children ages 12 to 15 on Monday. A pediatrician answers parents' questions about the shots.
Lire la suite »
FDA authorizes Pfizer COVID-19 boosters for 12- to 15-year oldsThe FDA on Monday authorized Pfizer COVID-19 boosters for 12- to 15-year olds amid the omicron surge as children head back to school.
Lire la suite »
FDA Backs Pfizer Booster for 12- to 15-Year-OldsThe agency also took two related actions in the revised emergency use authorization for the Pfizer/BioNTech vaccine.
Lire la suite »